EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents

Alessia Bono iD, Gabriele La Monica iD, Federica Alamia iD, Francesco Mingoia iD, Carla Gentile iD, Daniele Peri iD, Antonino Lauria iD, Annamaria Martorana iD

International Journal of Molecular Sciences · 06.09.2023 · 24 (18) · 13769

DOI: 10.3390/ijms241813769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.09.2023. Verfasst von Alessia Bono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche "STEBICEF", University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palerm…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Mammaplasty, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR, PNRR-M4C2, ECS_00000022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDK-1 and PARP-1 play crucial roles in breast cancer progression. Compounds acting as CDK-1 and/or PARP-1 inhibitors can induct cell death in breast cancer with a selective synthetic lethality mechanism. A mixed treatment by means of CDK-1 and PARP-1 inhibitors resulted in radical breast cancer cell growth reduction. Inhibitors with a dual target mechanism of action could arrest cancer progression by simultaneously blocking the DNA repair mechanism and cell cycle, resulting in advantageous monotherapy. To this aim, in the present work, we identified compound 645656 with a significant affinity for both CDK-1 and PARP-1 by a mixed ligand- and structure-based virtual screening protocol. The Biotarget Predictor Tool was used at first in a Multitarget mode to filter the large National Cancer Institute (NCI) database. Then, hierarchical docking studies were performed to further screen the compounds and evaluate the ligands binding mode, whose putative dual-target mechanism of action was investigated through the correlation between the antiproliferative activity data and the target proteins’ (CDK-1 and PARP-1) expression pattern. Finally, a Molecular Dynamics Simulation confirmed the high stability of the most effective selected compound 645656 in complex with both PARP-1 and CDK-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMammaplastyNeoplasmsPoly(ADP-ribose) Polymerase InhibitorsLigandsCell Cycle

Stichwörter der Autor:innen

CDK-1DRUDITNCI databasePARP-1breast cancerdinaciclibmultitarget mechanismolaparib

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsLigandsAntineoplastic Agents

Autor:innen und Institutionen

  • Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche "STEBICEF", University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.
  • Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), Consiglio Nazionale delle Ricerche (CNR), 90146 Palermo, Italy.
  • Dipartimento di Ingegneria dell'Innovazione Industriale e Digitale, Università degli Studi di Palermo, Viale 10 delle Scienze Ed. 6, 90128 Palermo, Italy.

ORCID-Profile: Alessia Bono, Gabriele La Monica, Federica Alamia, Francesco Mingoia, Carla Gentile, Daniele Peri, Antonino Lauria, Annamaria Martorana

Förderung

  • MUR
  • PNRR-M4C2
  • ECS_00000022
  • PJ_MIN_SALUTE_METODI_SOSTITUTIVI

Zitieren

APA

Bono, A., La Monica, G., Alamia, F., Mingoia, F., Gentile, C., Peri, D., Lauria, A., & Martorana, A. (2023). In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents. International Journal of Molecular Sciences, 24(18), 13769. https://doi.org/10.3390/ijms241813769

Vancouver

Bono A, La Monica G, Alamia F, Mingoia F, Gentile C, Peri D, et al. In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents. International Journal of Molecular Sciences. 2023;24(18):13769. doi:10.3390/ijms241813769

BibTeX
@article{Bono2023,
  author = {Bono, Alessia and La Monica, Gabriele and Alamia, Federica and Mingoia, Francesco and Gentile, Carla and Peri, Daniele and Lauria, Antonino and Martorana, Annamaria},
  title = {In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {18},
  pages = {13769},
  doi = {10.3390/ijms241813769}
}
Kostenlos starten →